Man Group
DNA icon

Man Group’s Ginkgo Bioworks DNA Stock Holding History

Man Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$669K Buy
+109,117
New +$908K ﹤0.01% 1983
2024
Q2 		– Sell
-18,946
Closed -$879K – 2073
2024
Q1 		$879K Buy
18,946
+17,110
+932% +$886K ﹤0.01% 1595
2023
Q4 		$124K Buy
+1,836
New +$112K ﹤0.01% 1965
2023
Q3 		– Hold
0
– – – 1877
2023
Q1 		– Hold
0
– – – 1958

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's DNA Position: Q1 2026 in Review

Man Group opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 109,117 shares worth $669K. The stake represents ﹤0.01% of the portfolio and ranks #1983 among its holdings. This is a return to the name: Man Group previously reported a position in DNA as recently as Q1 2024.

Man Group first reported a position in DNA in Q4 2023 and has held it in 3 quarters since. The position peaked at $879K in Q1 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Man Group held 109,117 shares of Ginkgo Bioworks worth $669K as of Q1 2026.
  • Ginkgo Bioworks was a new Man Group position in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1983 holding.
  • Man Group first reported a position in Ginkgo Bioworks in Q4 2023 and has held it in 3 quarters since.
  • Man Group's Ginkgo Bioworks position peaked at $879K in Q1 2024.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.